The US Food and Drug Administration alerted clinical laboratories and health care providers that mutations in the SARS-CoV-2 virus, including the B.1.1.7 variant, may result in false negative ..... see more
Source : Medtech Insight
In a move indicative of the unusual times the world finds itself in due to COVID-19, India has granted conditional accelerated approvals to two vaccines, one for which Phase III ..... see more
Source : 'The Pink Sheet'
The experiences of COVID-19 within the medtech industry have varied from company to company and from country to country. Asia was hardest hit by rising infections in the early months ..... see more
Source : Medtech Insight
Amid concerns about the rollout of vaccines against SARS-CoV-2 in the US, one of the companies that has received an emergency use authorization, Moderna, Inc., has raised the ..... see more
Source : 'Scrip Intelligence'
In a move indicative of the unusual times that the world finds itself in due to COVID-19, India granted conditional accelerated approvals to two vaccines, one of them still in ..... see more
Source : 'Scrip Intelligence'
The overall deal-making environment may have been scarred by the pandemic in 2020, but Indian firms appeared to emerge as partners of choice for scaling up COVID-19 therapies and expanding ..... see more
Source : 'Scrip Intelligence'
Many if not most of the drug adulteration regulatory actions by the US Food and Drug Administration in fiscal year 2021 will be based on alternatives to agency inspections that ..... see more
Source : 'HBW Insight'
Operation Warp Speed has run into some engine trouble. After helping drive development of a COVID vaccine in record time, OWS ended up falling short of its stated goal of ..... see more
Source : 'The Pink Sheet'
China's National Medical Products Administration announced 31 December that it has granted conditional approval to a COVID-19 vaccine developed by the state-owned China National Biotec Group.Since entering the ..... see more
Source : 'The Pink Sheet'
One of the first COVID-19 tests to gain emergency use authorization (EUA) from the US Food and Drug Administration could be giving false-negative results if not used properly, the agency ..... see more
Source : Medtech Insight
The spread of COVID-19 across the globe in early spring – and the resulting cancellation of in-person meetings and conferences – stifled the connection between bioharma companies and the global ..... see more
Source : IN VIVO
The number of containers of pharmaceuticals recalled in the US during the third quarter nearly doubled from the second quarter to nearly 33.8m as recalls increased nearly 50%, says Stericyle ..... see more
Source : 'HBW Insight'
OTC drug recalls in the US ended 2020 much the same way they were for much of the year as additional hand sanitizers made in Mexico were found to contain ..... see more
Source : 'HBW Insight'
While debate about the data behind AstraZeneca PLC and Oxford University’s COVID-19 vaccine rages on in Europe and the US, countries in South and Central America seem happy to ..... see more
Source : 'Scrip Intelligence'
The UK has granted a temporary authorization to AstraZeneca PLC and Oxford University’s COVID-19 vaccine, a move which has been hailed as a game-changer for the country and the ..... see more
Source : 'Scrip Intelligence'
The annus horribilis that was 2020 ends on a far more hopeful note than it began, with two vaccines against COVID-19 receiving emergency use authorizations from the US Food and ..... see more
Source : 'Scrip Intelligence'
While debate about the data behind AstraZeneca PLC and Oxford University’s COVID-19 vaccine continues in Europe and the US, countries in South and Central America seem happy to follow ..... see more
Source : 'The Pink Sheet'
Two new rules put forward by the US Department of Health and Human Services in the final days of the Trump administration could have a chilling effect on future guidance ..... see more
Source : Medtech Insight